Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 3/2014

Open Access 01-05-2014 | ePoster presentation

Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant adolescent women and its association with pregnancy outcomes

Authors: Priti Ghope, Subash C Sonkar, Kirti Wasnik, Pratima Mittal, Daman Saluja

Published in: BMC Infectious Diseases | Special Issue 3/2014

Login to get access

Excerpt

Sexually transmitted infections (STIs) are major cause for reproductive morbidity, infertility, long term disability and death amongst men, women and infants globally. T. vaginalis, N. gonorrhoeae and C. trachomatis are well established agents of STIs. In present study, we determined the prevalence of these infections in asymptomatic pregnant adolescent women using PCR and studied the association of these infections with maternal and fetal outcome. …
Metadata
Title
Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant adolescent women and its association with pregnancy outcomes
Authors
Priti Ghope
Subash C Sonkar
Kirti Wasnik
Pratima Mittal
Daman Saluja
Publication date
01-05-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue Special Issue 3/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-S3-E33

Other articles of this Special Issue 3/2014

BMC Infectious Diseases 3/2014 Go to the issue

Poster presentation

Spectrum and prognostic significance of parasitic infection in ART naïve HIV patients

Poster presentation

Identification of Corynebacterium jeikeium from a CAPD patient by 16S rDNA PCR – a case report

Poster presentation

Exploring the protein-protein interface of integrin-galectin complex for drug development against HIV infection- a bioinformatics study

ePoster presentation

Anti-HIV-1 activity of Sargassum swartzii a marine brown alga

ePoster presentation

Longer sequence insertions in p6 gag play a role in immune escape in HIV-1 subtype C

ePoster presentation

Assessment of the anti-HBV like property of BEHP – a phthalate derivative and its insilico characterization
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits